{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:55:47Z","timestamp":1791860147318,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijantimicag.2017.12.007","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T01:50:51Z","timestamp":1514166651000},"page":"687-692","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus \u03b2-lactams"],"prefix":"10.1016","volume":"51","author":[{"given":"Nicholas J.","family":"Mercuro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Stogsdill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minkey","family":"Wungwattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0010","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jac\/dkp131","article-title":"Outcomes of early switching from intravenous to oral antibiotics on medical wards","volume":"64","author":"Mertz","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.mcna.2006.07.009","article-title":"Oral antibiotic therapy of serious systemic infections","volume":"90","author":"Cunha","year":"2006","journal-title":"Med Clin N Am"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0020","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/106002809603000605","article-title":"Sequential parenteral and oral ciprofloxacin regimen versus parenteral therapy for bacteremia: a pharmacoeconomic analysis","volume":"30","author":"Amodio-Groton","year":"1996","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0025","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s10096-016-2661-5","article-title":"Effectiveness of sequential intravenous-to-oral antibiotic therapy in hospitalized patients with Gram-positive infection: the SEQUENCE cohort study","volume":"35","author":"Rodriguez-Pardo","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0030","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0035","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1186\/cc10545","article-title":"Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis","volume":"15","author":"Havey","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/jac\/43.suppl_1.117","article-title":"Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy","volume":"43","author":"Krumpe","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0045","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ijantimicag.2016.07.013","article-title":"Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections","volume":"48","author":"Kutob","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0050","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/0002-9343(89)90050-8","article-title":"Intravenous\/oral ciprofloxacin versus ceftazidime in the treatment of serious infections","volume":"87","author":"Fass","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0055","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1007\/s10620-014-3233-0","article-title":"Early oral antibiotic switch compared with conventional intravenous antibiotic therapy for acute cholangitis with bacteremia","volume":"59","author":"Park","year":"2014","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0060","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/0002-9343(89)90055-7","article-title":"Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections","volume":"87","author":"Peacock","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0065","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0002-9343(91)90181-V","article-title":"Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics","volume":"91","author":"Paladino","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0070","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cmi.2015.05.013","article-title":"Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization","volume":"21","author":"Brigmon","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/jhm.877","article-title":"The clinical impact of fluoroquinolone resistance in patients with E. coli bacteremia","volume":"6","author":"Camins","year":"2011","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0080","series-title":"Cipro\u00ae [package insert]","author":"Bayer Pharmaceuticals Corporation","year":"2016"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0085","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"P\u00e9pin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0090","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1001\/jama.2016.16201","article-title":"US emergency department visits for outpatient adverse drug events, 2013\u20132014","volume":"316","author":"Shehab","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0095","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/jac\/dkw226","article-title":"Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints","volume":"71","author":"de Velde","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0100","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/jac\/33.1.169","article-title":"Sequential therapy with intravenous and oral cephalosporins","volume":"33","author":"Janknegt","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0105","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.1128\/AAC.44.12.3264-3271.2000","article-title":"Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever","volume":"44","author":"Giamarellou","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0110","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intra-abdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0115","author":"Agency for Healthcare Research and Quality"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0120","author":"Agency for Healthcare Research and Quality"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0125","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/00019048-199409000-00005","article-title":"Treatment of Gram-negative aerobic bacteremia with sequential intravenous to oral ciprofloxacin","volume":"3","author":"Skoutelis","year":"1994","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0130","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00000658-199603000-00012","article-title":"Results of a randomized trial comparing sequential intravenous\/oral treatment with ciprofloxacin plus metronidazole to imipenem\/cilastatin for intra-abdominal infections","volume":"223","author":"Solomkin","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0135","author":"US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0140","author":"Healthcare Cost and Utilization Project"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0145","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1086\/650482","article-title":"Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America","volume":"50","author":"Hooton","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0150","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/diacare.3.1.187","article-title":"Infection and diabetes mellitus","volume":"3","author":"Wheat","year":"1980","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0155","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cid\/cix315","article-title":"An automated, pharmacist-driven initiative improves quality of care for Staphylococcus aureus bacteremia","volume":"65","author":"Wenzler","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s15010-017-1020-5","article-title":"Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections","volume":"45","author":"Nelson","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ijid.2016.12.018","article-title":"Short-course antimicrobial treatment for acute cholangitis with Gram-negative bacillary bacteremia","volume":"55","author":"Uno","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.12.007_bib0170","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/cid\/cix767","article-title":"Comparing the outcomes of adults with Enterobacteriaceae bacteremia receiving short-course versus prolonged-course antibiotic therapy in a multicenter, propensity score-matched cohort","volume":"66","author":"Chotprasitsakul","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917304417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917304417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T22:56:12Z","timestamp":1535151372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917304417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0924857917304417"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.12.007","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retrospective analysis comparing oral stepdown therapy for enterobacteriaceae bloodstream infections: fluoroquinolones versus \u03b2-lactams","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}